focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFair Oaks Inc21 Regulatory News (FAIR)

Share Price Information for Fair Oaks Inc21 (FAIR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.5975
Bid: 0.59
Ask: 0.605
Change: -0.0075 (-1.24%)
Spread: 0.015 (2.542%)
Open: 0.605
High: 0.605
Low: 0.5975
Prev. Close: 0.605
FAIR Live PriceLast checked at -
Fair Oaks Income 2017 is an Investment Trust

To generate attractive, risk-adjusted returns, principally through income distributions, mainly invests in US and European CLOs or other vehicles.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

8 Jun 2023 15:12

RNS Number : 1504C
Fair Oaks Income Limited
08 June 2023
 

8 June 2023

 

Fair Oaks Income Limited

(Incorporated in Guernsey under The Companies (Guernsey) Law, 2008, as amended, with registered number 58123 and registered as a Registered Closed-ended Collective Investment Scheme with the Guernsey Financial Services Commission)

 

Result of Annual General Meeting

 

Fair Oaks Income Limited (the "Company") announces that, at the Annual General Meeting of the Company held earlier today, ordinary resolutions 1 to 8 were passed on a poll. Extraordinary resolution 9 did not achieve the 75% majority of votes cast in favour in order to pass and therefore resolution 10 was not proposed.

 

The Directors note that less than half of the issued share capital was voted and is disappointed with this low turnout.

 

The Board notes that a substantial number of shares were voted against resolutions 2, 3 and 4 regarding the re-election and election of the Directors by a single shareholder. The Directors will be consulting with this shareholder in order to understand their reasons for voting in this way and to consider any action that should be taken as a consequence.

 

Through resolution 9 the Directors were seeking authority for the disapplication of pre-emption rights in respect of a total of up to approximately 10 per cent. of the existing 2021 Shares in issue. The Board believes the passing of this resolution would have been in the best interests of Shareholders given shares would only have been issued at a premium to the Company's prevailing net asset value. However, given that the Company's shares are currently trading at a discount to the Company's net asset value, the Directors do not believe that the failure to pass the issuance resolution will be restrictive to the Company in the near term.

 

The proxy votes received by the Company were as follows:

 

Resolution

For

Against

Withheld*

Votes

%

Votes

%

Votes

1. Financial Statements and Directors' Report for the year ended 31 December 2022

214,427,357

100

0

0

29,766

2. Re-election of Claudio Albanese as a Director

114,266,138

53.28

100,161,219

46.72

29,766

3. Re-election of Jonathan Bridel as a Director

114,266,138

53.28

100,161,219

46.72

29,766

4. Election of Fionnuala Carvill as a Director

142,448,100

66.42

71,979,257

33.58

29,766

5. Re-appointment of KPMG as Auditor

186,228,195

86.85

28,199,162

13.15

29,766

6. Authorise the Directors to determine the remuneration of the Auditor

214,423,049

99.99

4,308

0.01

29,766

7. Approval of the dividend policy

214,406,357

99.99

21,000

0.01

29,766

8. Authority to make market purchases of the Company's Realisation Shares and 2021 Shares

198,631,349

92.63

15,796,008

7.37

29,766

9. Authority to issue up to 39.4 million 2021 Shares

142,353,517

66.38

72,068,660

33.62

34,946

10. Authority to issue up to a further 39.4 million 2021 Shares

Withdrawn

 

*A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes "For" or "Against" the resolution. Resolutions 1 to 8 were proposed as Ordinary Resolutions and resolutions 9 and 10 were proposed as Extraordinary Resolutions.

 

In accordance with LR 9.6.18, details of those resolutions passed at the AGM that were not in the ordinary course of business are detailed below.

 

8. THAT the Company be and is hereby generally and unconditionally authorised in accordance with Section 315 of The Companies (Guernsey) Law, 2008 (as amended) (the "Law") (subject to all applicable legislation and regulations) to make market acquisitions (as defined in the Law) of its 2021 Shares and of its Realisation Shares in issue, provided that:

 

a. the maximum number of 2021 Shares hereby authorised to be purchased is 14.99 per cent. per annum of the 2021 Shares in issue immediately following the passing of this resolution;

 

b. the maximum number of Realisation Shares hereby authorised to be purchased is 14.99 per cent. per annum of the Realisation Shares in issue immediately following the passing of this resolution

 

c. the minimum price (exclusive of expenses) which may be paid per 2021 Share or per Realisation Share is 1 US cent;

 

d. the maximum price (exclusive of expenses) which may be paid for a 2021 Share or per Realisation Share shall be not more than the higher of (i) 5 per cent. above the average market value of the relevant class of shares for the five business days prior to the day the purchase is made and (ii) the higher of the price of the last independent trade and the highest independent bid at the time of the purchase for any number of the relevant class of shares on the trading venues where the purchase is carried out;

 

e. the authority hereby conferred shall expire at the conclusion of the next annual general meeting of the Company held in 2024 or 15 months from the date of this resolution, whichever is the earlier, unless such authority is varied, revoked or renewed prior to such time;

 

f. the Company may make a contract to purchase 2021 Shares or Realisation Shares under the authority hereby conferred prior to the expiry of such authority which will or may be executed wholly or partly after the expiration of such authority and may make an acquisition of 2021 Shares or Realisation Shares pursuant to any such contract; and

 

g. any 2021 Shares or Realisation Shares bought back may be held as treasury shares in accordance with the Law or be subsequently cancelled by the Company.

 

9. THAT the Directors of the Company be and are hereby empowered to issue the following shares in the Company or rights to subscribe for such shares in the Company for cash as if the pre-emption provisions contained under Article 6.2 of the Company's articles of incorporation did not apply to any such issues provided that this power shall be limited to the issue of the below-mentioned shares or of rights to subscribe for the below-mentioned shares:

 

(i) up to a maximum number of 39.4 million 2021 Shares;

 

that such power shall expire on the earlier of the conclusion of the next annual general meeting of the Company or on the expiry of 15 months from the passing of this Resolution except that the Company may before such expiry make offers or agreements which would or might require 2021 Shares or rights to subscribe for such shares in the Company to be issued after such expiry and notwithstanding such expiry the Directors may issue 2021 Shares or rights to subscribe for such shares in the Company in pursuance of such offers or agreements as if the power conferred hereby had not expired.

 

10. THAT the Directors of the Company be and are hereby empowered to issue the following shares in the Company or rights to subscribe for such shares in the Company, in addition to that which is referred to in Resolution 9, for cash as if the pre-emption provisions contained under Article 6.2 of the Company's articles of incorporation did not apply to any such further issues provided that this power shall be limited to the issue of the below-mentioned shares or of rights to subscribe for the below-mentioned shares:

 

(i) up to a maximum number of a further 39.4 million 2021 Shares;

 

that such power shall expire on the earlier of the conclusion of the next annual general meeting of the Company or on the expiry of 15 months from the passing of this Resolution except that the Company may before such expiry make offers or agreements which would or might require 2021 Shares or rights to subscribe for such shares in the Company to be issued after such expiry and notwithstanding such expiry the Directors may issue 2021 Shares or rights to subscribe for such shares in the Company in pursuance of such offers or agreements as if the power conferred hereby had not expired.

 

 

 

LEI: 2138008KETEC1WM5YP90

 

Enquiries:

 

Fair Oaks Income Limited

Email: contact@fairoaksincome.com

Web: www.fairoaksincome.com

 

Fair Oaks Capital Limited

Investor Relations

DDI: +44 (0) 20 3034 0400

Email: ir@fairoakscap.com

 

Sanne Fund Services (Guernsey) Limited

Ben Le Prevost

DDI: +44 (0) 20 3530 3105

Email: Ben.LePrevost@apexfs.group

 

Numis Securities Limited

Nathan Brown, Investment Banking

DDI: +44 (0) 20 7260 1426

Email: n.brown@numis.com

 

Liberum Capital Limited

Chris Clarke, Investment Banking

DDI: +44 (0) 20 3100 2190

Email: chris.clarke@liberum.com

 

Fair Oaks Income Limited

 

Fair Oaks Income Limited is a registered closed-ended investment company incorporated in Guernsey. The Company was admitted to trading on the Specialist Fund Market of the London Stock Exchange (now the Specialist Fund Segment of the Main Market of the London Stock Exchange) on 12 June 2014.

 

The investment policy of the Company is to invest (either directly and/or indirectly through FOIF II LP and FOMC III LP) in US and European CLOs or other vehicles and structures which provide exposure to portfolios consisting primarily of US and European floating-rate senior secured loans and which may include non-recourse financing.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSSFLAEDSEFM
Date   Source Headline
13th Nov 20207:00 amRNSNet Asset Value(s)
11th Nov 202010:28 amRNSDividend Currency Election
23rd Oct 20205:04 pmRNSReinvestment of Management Fees
21st Oct 20207:00 amRNSAppointment of Joint Corporate Broker
20th Oct 20207:00 amRNSNet Asset Value(s)
20th Oct 20207:00 amRNSDividend Declaration
30th Sep 20209:14 amRNSHolding(s) in Company
17th Sep 202012:40 pmRNSPublication of Interim Financial Report
15th Sep 20207:00 amRNSNet Asset Value(s)
10th Sep 202010:50 amRNSDirector/PDMR Shareholding
9th Sep 20204:15 pmRNSInterim Financial Report
19th Aug 20207:00 amRNSNet Asset Value(s)
10th Aug 20205:03 pmRNSDividend Currency Election
30th Jul 20202:32 pmRNSDividend Declaration
24th Jul 202011:06 amRNSSecond Price Monitoring Extn
24th Jul 202011:01 amRNSPrice Monitoring Extension
20th Jul 20207:00 amRNSNet Asset Value(s)
20th Jul 20207:00 amRNSCompany Update on Dividends
1st Jul 20202:22 pmRNSHolding(s) in Company
19th Jun 20203:59 pmRNSHolding(s) in Company
16th Jun 20207:00 amRNSNet Asset Value(s)
11th Jun 202012:56 pmRNSResult of AGM
22nd May 202011:06 amRNSSecond Price Monitoring Extn
22nd May 202011:02 amRNSPrice Monitoring Extension
19th May 20207:00 amRNSNet Asset Value(s)
1st May 20208:00 amRNSTotal Voting Rights
27th Apr 20204:00 pmRNSNotice of AGM
27th Apr 20207:00 amRNSIssue of Shares
24th Apr 20207:00 amRNSIssue of Shares
22nd Apr 202011:07 amRNSSecond Price Monitoring Extn
22nd Apr 202011:01 amRNSPrice Monitoring Extension
17th Apr 20203:00 pmRNSAnnual Financial Report
17th Apr 20207:00 amRNSIssue of Shares
15th Apr 20207:00 amRNSNet Asset Value(s)
2nd Apr 20209:05 amRNSSecond Price Monitoring Extn
2nd Apr 20209:00 amRNSPrice Monitoring Extension
1st Apr 202011:05 amRNSSecond Price Monitoring Extn
1st Apr 202011:02 amRNSPrice Monitoring Extension
1st Apr 20209:06 amRNSSecond Price Monitoring Extn
1st Apr 20209:01 amRNSPrice Monitoring Extension
31st Mar 20202:09 pmRNSSecond Price Monitoring Extn
31st Mar 20202:01 pmRNSPrice Monitoring Extension
31st Mar 202011:07 amRNSSecond Price Monitoring Extn
31st Mar 202011:01 amRNSPrice Monitoring Extension
30th Mar 202011:06 amRNSSecond Price Monitoring Extn
30th Mar 202011:01 amRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSCompany Update
20th Mar 20207:00 amRNSNet Asset Value(s)
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:38 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.